Status:
COMPLETED
Supraclavicular Brachial Plexus Block During Upper Limb Surgeries
Lead Sponsor:
Sohag University
Conditions:
Brachial Plexus Block
Eligibility:
All Genders
18-75 years
Phase:
EARLY_PHASE1
Brief Summary
Comparative Study Between Ketamine-Bupivacaine Versus Bupivacaine With Intravenous Ketamine Infusion In Supraclavicular Brachial Plexus Block During Upper limb Surgeries The techniques of regional ane...
Eligibility Criteria
Inclusion
- Age 18 to 75 years.
- ASA physical status I-II, scheduled.
- Patients of either sex.
- Unilateral elective upper limb surgeries undergoing under ultrasound guided supraclavicular brachial plexus block.
Exclusion
- Patient refusal.
- Patients with peripheral neuropathy of the upper limb.
- Infection at the injection site.
- Uncontrolled diabetes, epilepsy, obstructive pulmonary disease and neuromuscular disease.
- Altered mental status.
- Hypersensitivity to bupivacaine and ketamine.
- Patients with coagulopathy.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05315271
Start Date
June 1 2022
End Date
January 20 2023
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt